Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy C Sturm

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Journal of Clinical Lipidology|September 15, 2024
Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH studyGemme Campbell-Salome, Kelly M Morgan, Jazmine Gabriel, et al.
Circulation. Genomic and Precision Medicine|March 27, 2023
Interpreting Incidentally Identified Variants in Genes Associated With Heritable Cardiovascular Disease: A Scientific Statement From the American Heart AssociationAndrew P Landstrom, Anwar A Chahal, Michael J Ackerman, et al.
Circulation. Genomic and Precision Medicine|October 26, 2018
Healthcare Utilization and Patients' Perspectives After Receiving a Positive Genetic Test for Familial HypercholesterolemiaLaney K Jones, Alanna Kulchak Rahm, Kandamurugu Manickam, et al.
JACC. Cardiooncology|November 8, 2021
Genomic Screening for Pathogenic Transthyretin Variants Finds Evidence of Underdiagnosed Amyloid Cardiomyopathy From Health RecordsBrendan J Carry, Katelyn Young, Samuel Fielden, et al.
Journal of the American Heart Association|August 25, 2021
Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial HypercholesterolemiaAnandita Agarwala, Nathan Bekele, Elena Deych, et al.
Journal of Genetic Counseling|December 7, 2016
Counselees' Perspectives of Genomic Counseling Following Online Receipt of Multiple Actionable Complex Disease and Pharmacogenomic Results: a Qualitative Research StudyKevin Sweet, Shelly Hovick, Amy C Sturm, et al.
Implementation Science Communications|March 20, 2021
Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysisLaney K Jones, Megan McMinn, David Kann, et al.
JAMA Cardiology|May 26, 2021
Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia DiagnosisAmy C Sturm, Rebecca Truty, Thomas E Callis, et al.
Circulation. Genomic and Precision Medicine|July 13, 2018
Managing Secondary Genomic Findings Associated With Arrhythmogenic Right Ventricular Cardiomyopathy: Case Studies and Proposal for Clinical SurveillanceChristopher M Haggerty, Brittney Murray, Crystal Tichnell, et al.
Journal of Personalized Medicine|July 2, 2021
Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH StudyLaney K Jones, Nicole Walters, Andrew Brangan, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Journal of Clinical Lipidology|September 15, 2024
Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH studyGemme Campbell-Salome, Kelly M Morgan, Jazmine Gabriel, et al.
Circulation. Genomic and Precision Medicine|March 27, 2023
Interpreting Incidentally Identified Variants in Genes Associated With Heritable Cardiovascular Disease: A Scientific Statement From the American Heart AssociationAndrew P Landstrom, Anwar A Chahal, Michael J Ackerman, et al.
Circulation. Genomic and Precision Medicine|October 26, 2018
Healthcare Utilization and Patients' Perspectives After Receiving a Positive Genetic Test for Familial HypercholesterolemiaLaney K Jones, Alanna Kulchak Rahm, Kandamurugu Manickam, et al.
JACC. Cardiooncology|November 8, 2021
Genomic Screening for Pathogenic Transthyretin Variants Finds Evidence of Underdiagnosed Amyloid Cardiomyopathy From Health RecordsBrendan J Carry, Katelyn Young, Samuel Fielden, et al.
Journal of the American Heart Association|August 25, 2021
Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial HypercholesterolemiaAnandita Agarwala, Nathan Bekele, Elena Deych, et al.
Journal of Genetic Counseling|December 7, 2016
Counselees' Perspectives of Genomic Counseling Following Online Receipt of Multiple Actionable Complex Disease and Pharmacogenomic Results: a Qualitative Research StudyKevin Sweet, Shelly Hovick, Amy C Sturm, et al.
Implementation Science Communications|March 20, 2021
Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysisLaney K Jones, Megan McMinn, David Kann, et al.
JAMA Cardiology|May 26, 2021
Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia DiagnosisAmy C Sturm, Rebecca Truty, Thomas E Callis, et al.
Circulation. Genomic and Precision Medicine|July 13, 2018
Managing Secondary Genomic Findings Associated With Arrhythmogenic Right Ventricular Cardiomyopathy: Case Studies and Proposal for Clinical SurveillanceChristopher M Haggerty, Brittney Murray, Crystal Tichnell, et al.
Journal of Personalized Medicine|July 2, 2021
Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH StudyLaney K Jones, Nicole Walters, Andrew Brangan, et al.
Pageof 12